ADAGENE INC-ADR (ADAG) Fundamental Analysis & Valuation
NASDAQ:ADAG • US0053291078
Current stock price
3.77 USD
-0.37 (-8.94%)
Last:
This ADAG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ADAG Profitability Analysis
1.1 Basic Checks
- ADAG had negative earnings in the past year.
- ADAG had a negative operating cash flow in the past year.
- In the past 5 years ADAG always reported negative net income.
- In the past 5 years ADAG always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -44.94%, ADAG is in line with its industry, outperforming 51.83% of the companies in the same industry.
- ADAG has a Return On Equity (-78.84%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.94% | ||
| ROE | -78.84% | ||
| ROIC | N/A |
ROA(3y)-35.43%
ROA(5y)-39.1%
ROE(3y)-63.08%
ROE(5y)-60.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ADAG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ADAG Health Analysis
2.1 Basic Checks
- ADAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ADAG has more shares outstanding
- ADAG has more shares outstanding than it did 5 years ago.
- ADAG has a worse debt/assets ratio than last year.
2.2 Solvency
- ADAG has an Altman-Z score of -3.73. This is a bad value and indicates that ADAG is not financially healthy and even has some risk of bankruptcy.
- ADAG's Altman-Z score of -3.73 is in line compared to the rest of the industry. ADAG outperforms 43.35% of its industry peers.
- ADAG has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
- ADAG has a Debt to Equity ratio of 0.06. This is comparable to the rest of the industry: ADAG outperforms 41.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.73 |
ROIC/WACCN/A
WACC7.76%
2.3 Liquidity
- A Current Ratio of 2.29 indicates that ADAG has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.29, ADAG is doing worse than 73.41% of the companies in the same industry.
- ADAG has a Quick Ratio of 2.29. This indicates that ADAG is financially healthy and has no problem in meeting its short term obligations.
- ADAG has a worse Quick ratio (2.29) than 70.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.29 |
3. ADAG Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 10.98% over the past year.
- Looking at the last year, ADAG shows a very negative growth in Revenue. The Revenue has decreased by -87.35% in the last year.
- Measured over the past years, ADAG shows a very negative growth in Revenue. The Revenue has been decreasing by -26.47% on average per year.
EPS 1Y (TTM)10.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
Revenue 1Y (TTM)-87.35%
Revenue growth 3Y-78.36%
Revenue growth 5Y-26.47%
Sales Q2Q%N/A
3.2 Future
- ADAG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.90% yearly.
- ADAG is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.87% yearly.
EPS Next Y16.65%
EPS Next 2Y-4.5%
EPS Next 3Y4.25%
EPS Next 5Y4.9%
Revenue Next Year-58.56%
Revenue Next 2Y-30.25%
Revenue Next 3Y-16.33%
Revenue Next 5Y-14.87%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ADAG Valuation Analysis
4.1 Price/Earnings Ratio
- ADAG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year ADAG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.5%
EPS Next 3Y4.25%
5. ADAG Dividend Analysis
5.1 Amount
- No dividends for ADAG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ADAG Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:ADAG (3/27/2026, 4:30:00 PM)
3.77
-0.37 (-8.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-23 2026-03-23/amc
Earnings (Next)08-10 2026-08-10
Inst Owners28.63%
Inst Owner Change-46.01%
Ins Owners13.58%
Ins Owner Change0%
Market Cap177.60M
Revenue(TTM)103.20K
Net Income(TTM)-29.89M
Analysts83.08
Price Target10.38 (175.33%)
Short Float %0.16%
Short Ratio0.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.34%
PT rev (3m)10.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.55%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-46.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1720.96 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.68 | ||
| P/tB | 4.68 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.73
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0
BVpS0.8
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.94% | ||
| ROE | -78.84% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-35.43%
ROA(5y)-39.1%
ROE(3y)-63.08%
ROE(5y)-60.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 4.25% | ||
| Cap/Sales | 22.77% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.29 | ||
| Altman-Z | -3.73 |
F-Score2
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)24.44%
Cap/Depr(5y)80.95%
Cap/Sales(3y)13.48%
Cap/Sales(5y)39.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
EPS Next Y16.65%
EPS Next 2Y-4.5%
EPS Next 3Y4.25%
EPS Next 5Y4.9%
Revenue 1Y (TTM)-87.35%
Revenue growth 3Y-78.36%
Revenue growth 5Y-26.47%
Sales Q2Q%N/A
Revenue Next Year-58.56%
Revenue Next 2Y-30.25%
Revenue Next 3Y-16.33%
Revenue Next 5Y-14.87%
EBIT growth 1Y9.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.1%
EBIT Next 3Y-15.12%
EBIT Next 5YN/A
FCF growth 1Y-4.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.38%
OCF growth 3YN/A
OCF growth 5YN/A
ADAGENE INC-ADR / ADAG Fundamental Analysis FAQ
What is the fundamental rating for ADAG stock?
ChartMill assigns a fundamental rating of 1 / 10 to ADAG.
What is the valuation status for ADAG stock?
ChartMill assigns a valuation rating of 0 / 10 to ADAGENE INC-ADR (ADAG). This can be considered as Overvalued.
What is the profitability of ADAG stock?
ADAGENE INC-ADR (ADAG) has a profitability rating of 1 / 10.
What is the earnings growth outlook for ADAGENE INC-ADR?
The Earnings per Share (EPS) of ADAGENE INC-ADR (ADAG) is expected to grow by 16.65% in the next year.